Clinical Trials Directory

Trials / Unknown

UnknownNCT04621773

Live Birth Rate in Patients With Unexplained Recurrent Pregnancy Loss

Comparing the Live Birth Rate of Preimplantation Genetic Screening Versus Spontaneous Pregnancy in Patients With Unexplained Recurrent Pregnancy Loss

Status
Unknown
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Peking University Third Hospital · Academic / Other
Sex
Female
Age
20 Years – 45 Years
Healthy volunteers
Not accepted

Summary

STUDY AIM: to study the pregnancy outcomes and offspring development of patient with Unexplained Recurrent Pregnancy Loss Treated by PGS and spontaneous pregnancy, and to compare the health economic indicators and patient satisfaction of the two modes of pregnancy, so as to better guide the clinical treatment.

Detailed description

400 patients with two times or more unexplained pregnancy loss, who wants to be pregnant via preimplantation genetic screening procedure or spontaneous pregnancy are intended to be enrolled. They are going to divided into two groups: PGS(preimplantation genetic screening) group and SP(spontaneous pregnancy) group. The pregnancy outcomes and offspring development of those patients will be followed up by our investigators.

Conditions

Interventions

TypeNameDescription
PROCEDUREPreimplantation Genetic Screening(exposure)Preimplantation genetic screening (PGS) was developed in the late 1980s as an alternative to prenatal diagnosis for couples at risk of transmitting a genetic or chromosomal abnormality to their children. In embryos created through in vitro fertilisation (IVF), cells are biopsied and analysed using genetic tests such as polymerase chain reaction and fluorescent in situ hybridisation (FISH).

Timeline

Start date
2020-09-01
Primary completion
2023-09-01
Completion
2025-09-01
First posted
2020-11-09
Last updated
2020-11-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04621773. Inclusion in this directory is not an endorsement.